{
    "eid": "2-s2.0-85007416101",
    "title": "Unmet needs in Parkinson's disease: New horizons in a changing landscape",
    "cover-date": "2016-12-01",
    "subject-areas": [
        {
            "$": "Geriatrics and Gerontology",
            "@code": "2717"
        },
        {
            "$": "Neurology",
            "@code": "2808"
        },
        {
            "$": "Neurology (clinical)",
            "@code": "2728"
        }
    ],
    "keywords": [
        "Non-motor symptoms",
        "Parkinson's disease",
        "Pathogenesis",
        "Service provision",
        "Unmet needs"
    ],
    "authors": [
        "K. Ray Chaudhuri"
    ],
    "citedby-count": 19,
    "ref-count": 99,
    "ref-list": [
        "Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030",
        "The current and projected economic burden of Parkinson's disease in the United States",
        "Quality of life in Parkinson's disease patients with motor fluctuations and dyskinesias in five European countries",
        "Relation of subjective quality of life to motor symptom profile in Parkinson's disease",
        "Nocturnal journey of body and mind in Parkinson's disease: The manifestations, risk factors and their relationship to daytime symptoms. Evidence from the NIGHT-PD study",
        "The contribution of the MPTP-treated primate model to the development of new treatment strategies for Parkinson's disease",
        "Modeling Parkinson's disease",
        "Non motor subtypes and Parkinson's disease",
        "Prediagnostic presentations of Parkinson's disease in primary care: A case-control study",
        "Staging of brain pathology related to sporadic Parkinson's disease",
        "Pathogenesis of Parkinson disease - The gut-brain axis and environmental factors",
        "Advances in the mechanisms of parkinson's disease",
        "Animal Models of Parkinson's Disease: A Gateway to Therapeutics?",
        "MDS clinical diagnostic criteria for Parkinson's disease",
        "Monitoring of 30 marker candidates in early Parkinson disease as progression markers",
        "A colonic biomarker of Parkinson's disease?",
        "Progression and biomarkers for Parkinson disease: Merging motor with nonmotor symptoms",
        "Protein biomarkers in Parkinson's disease: Focus on cerebrospinal fluid markers and synaptic proteins",
        "A 'birds eye view on the current status and potential benefits of blood biomarkers for Parkinsons disease",
        "Cerebrospinal fluid biomarkers in Parkinson disease",
        "Alimentary, my dear Watson? The challenges of enteric \u03b1-synuclein as a Parkinson's disease biomarker",
        "Advances in Biomarker Research in Parkinson\u2019s Disease",
        "Emerging candidate biomarkers for Parkinson's disease: A review",
        "Biomarkers for the diagnosis and management of Parkinson's disease",
        "Biomarkers of Parkinson's disease: Present and future",
        "Postural instability and gait are associated with severity and prognosis of Parkinson disease",
        "Gait and balance in Parkinson\u2019s disease subtypes: objective measures and classification considerations",
        "How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale",
        "Prognostic factors for the progression of Parkinson's disease: A systematic review",
        "Activities of daily living and quality of life in persons with newly diagnosed Parkinson's disease according to subtype of disease, and in comparison to healthy controls",
        "Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies",
        "Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach",
        "A clinico-pathological study of subtypes in Parkinson's disease",
        "Nonmotor features of Parkinson's disease subtypes",
        "How stable are Parkinson's disease subtypes in de novo patients: Analysis of the PPMI cohort?",
        "A double-blind, delayed-start trial of rasagiline in Parkinson's disease",
        "The delayed-start study in Parkinson disease: Can't satisfy everyone",
        "Are delayed-start design trials to show neuroprotection in Parkinson's disease fundamentally flawed?",
        "Prerequisites to launch neuroprotective trials in Parkinson's disease: An industry perspective",
        "Endpoints and analyses to discern disease-modifying drug effects in early Parkinson's disease",
        "Preclinical biomarkers of parkinson disease",
        "Levodopa and the progression of parkinson\u2019s disease",
        "Novel Approaches to Optimization of Levodopa Therapy for Parkinson\u2019s Disease",
        "Nonmotor fluctuations in Parkinson disease: Severity and correlation with motor complications",
        "Unmet needs of patients with Parkinson's disease: Interview survey of patients and caregivers",
        "Impact of the motor complications of Parkinson's disease on the quality of life",
        "Characterizing motor and non-motor aspects of early-morning off periods in Parkinson's disease: An international multicenter study",
        "Apomorphine Subcutaneous Injection for the Management of Morning Akinesia in Parkinson's Disease",
        "Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease",
        "Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's disease",
        "When do levodopa motor fluctuations first appear in Parkinson's disease?",
        "Gastric motor dysfunctions in Parkinson's disease: Current pre-clinical evidence",
        "Gastrointestinal dysfunction in Parkinson's disease",
        "Gastrointestinal dysfunction in Parkinson's disease",
        "Waiting for ON: A major problem in patients with Parkinson disease and ON/OFF motor fluctuations",
        "How well do Parkinson's disease patients turn in bed? Quantitative analysis of nocturnal hypokinesia using multisite wearable inertial sensors",
        "A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations",
        "Novel formulations and modes of delivery of levodopa",
        "Non-motor parkinson\u2019s: Integral to motor parkinson\u2019s, yet often neglected",
        "The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease",
        "The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: An international study using the nonmotor symptoms questionnaire",
        "New clinical trials for nonmotor manifestations of Parkinson's disease",
        "Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): A double-blind, randomised, placebo-controlled trial",
        "Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double-blind, randomized, placebo-controlled study (RECOVER)",
        "Nonmotor fluctuations in Parkinson's disease: Frequent and disabling",
        "EuroInf: A multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson's disease",
        "Interdisciplinary Teamwork for the Treatment of People with Parkinson\u2019s Disease and Their Families",
        "Effective delivery of apomorphine in the management of parkinson disease: Practical considerations for clinicians and parkinson nurses",
        "Specialist nurses save money and improve care.",
        "Effects of community based nurses specialising in Parkinson's disease on health outcome and costs: Randomised controlled trial",
        "Multidisciplinary rehabilitation in Parkinson's disease: A milestone with future challenges",
        "Physiotherapy versus placebo or no intervention in Parkinson's disease",
        "The effectiveness of physiotherapy treatment on balance dysfunction and postural instability in persons with Parkinson's disease: A systematic review and meta-analysis",
        "Complementary physical therapies for movement disorders in Parkinson's disease: A systematic review",
        "Efficacy of occupational therapy for patients with Parkinson's disease: A randomised controlled trial",
        "In-patient multidisciplinary rehabilitation for Parkinson's disease: A randomized controlled trial"
    ],
    "affiliation": [
        {
            "affiliation-city": "Tokyo",
            "affilname": "Juntendo University",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "London",
            "affilname": "King's College Hospital",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Groningen",
            "affilname": "Rijksuniversiteit Groningen",
            "affiliation-country": "Netherlands"
        }
    ],
    "funding": [
        "Britannia Pharmaceuticals",
        "Chulalongkorn Academic Advancement Fund",
        "Kings College, London",
        "National Parkinson Foundation",
        "National Institute on Handicapped Research",
        "Chulalongkorn University",
        "Thailand Research Fund",
        "Thailand Research Fund",
        "National Research Council of Thailand",
        "National Research Council of Thailand"
    ]
}